493
Views
13
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics

, , , , , & show all
Pages 1054-1059 | Received 29 Jun 2015, Accepted 05 Sep 2015, Published online: 19 Oct 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rouslan Kotchetkov, Erin Ellison, Jesse McLean, Bryn Pressnail & Derek Nay. (2018) Synchronous dual hematological malignancies: new or underreported entity?. Hematology 23:9, pages 596-599.
Read now
Claire van de Ree–Pellikaan, Lina van der Straten, Jurgen A. Riedl, Mark-David Levin & Peter E. Westerweel. (2017) High coincidence of chronic lymphocytic leukemia and myeloproliferative neoplasms: detection bias or a clue to a common pathophysiological path?. Leukemia & Lymphoma 58:3, pages 756-757.
Read now

Articles from other publishers (11)

Giuseppe Visani, Maryam Etebari, Fabio Fuligni, Antonio Di Guardo, Alessandro Isidori, Federica Loscocco, Stefania Paolini, Mohsen Navari & Pier Paolo Piccaluga. (2023) Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis. Cancers 15:6, pages 1785.
Crossref
Insija Selene, Aasems Jacob, Zain Mary El-Amir, Sanjivani Sathe & Asma Taj. (2023) A Tale of Two Hematological Malignancies: CML Followed by CLL in the Same Patient. Annals of Internal Medicine: Clinical Cases 2:1.
Crossref
Hongkyung Kim, Hye Min Kim, Jin Ju Kim, Saeam Shin, Doh Yu Hwang, Seung-Tae Lee & Jong Rak Choi. (2022) Concomitant Diagnosis of Primary Bone Marrow B-Cell Non-Hodgkin Lymphoma and Essential Thrombocythemia: A Case Report. Annals of Laboratory Medicine 42:2, pages 282-285.
Crossref
Francesco Angotzi, Andrea Visentin, Federico Scarmozzino, Alessandro Cellini, Roberta Bertorelle, Marco Pizzi, Gianni Binotto, Angelo Paolo Dei Tos & Livio Trentin. (2022) Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases. Current Oncology 29:3, pages 1455-1460.
Crossref
Nikolaos Sousos, Gemma Buck, Alba Rodriguez-Meira, Ruggiero Norfo, Angela Hamblin, Francesco Pezzella, Jennifer Davies, Philip Hublitz, Bethan Psaila & Adam J. Mead. (2020) Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis. HemaSphere 4:3, pages e356.
Crossref
Thomas Chalopin, Nicolas Vallet, Flavie Arbion, Carole Barin, Emmanuelle Rault, Alban Villate, Martin Eloit, Laurianne Drieu La Rochelle, Amélie Foucault, Marjan Ertault, Caroline Dartigeas, Lotfi Benboubker, Marie-Hélène Estienne, Jorge Domenech, Olivier Hérault & Emmanuel Gyan. (2019) Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo2study). Annals of Hematology 98:10, pages 2367-2377.
Crossref
Naveen Pemmaraju, Hagop Kantarjian, Loretta Nastoupil, Megan DupuisLisa ZhouSherry PierceKeyur P. Patel, Lucia Masarova, Jorge Cortes & Srdan Verstovsek. (2019) Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy. Blood 133:21, pages 2348-2351.
Crossref
James A. KennedyJessie J. F. MedeirosStephanie M. DobsonAndrea Arruda, Mahadeo A. Sukhai, Tracy Stockley, Anne Tierens, Mark D. Minden, Suzanne Kamel-Reid, John E. Dick & Vikas Gupta. (2018) Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasms. Blood 132:20, pages 2201-2205.
Crossref
Fares Darawshy, Arieh Ben-Yehuda, Karine Atlan & Deborah Rund. (2018) Chronic Lymphocytic Leukemia and Myelofibrosis. Case Reports in Hematology 2018, pages 1-5.
Crossref
Dimitri Guala, Kristoffer Bernhem, Hammou Ait Blal, Daniel Jans, Emma Lundberg, Hjalmar Brismar & Erik L L Sonnhammer. (2018) Experimental validation of predicted cancer genes using FRET. Methods and Applications in Fluorescence 6:3, pages 035007.
Crossref
T. Batt, E. Tegg & A. Johnston. (2016) Myeloproliferative neoplasms: association with lymphoproliferative disorders; a single institution experience. Pathology 48:6, pages 637-639.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.